Cleared Traditional

K841562 - HESUNG BLOOD TRANSFUSION SETS

K841562 is the FDA 510(k) clearance for HESUNG BLOOD TRANSFUSION SETS by Amkor Trading Co.. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K841562 · Amkor Trading Co. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1984
Decision
97d
Days
Class 2
Risk

K841562 is an FDA 510(k) clearance for the HESUNG BLOOD TRANSFUSION SETS. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Amkor Trading Co. (Walker, US). The FDA issued a Cleared decision on July 23, 1984 after a review of 97 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Amkor Trading Co. devices

Submission Details

510(k) Number K841562 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 1984
Decision Date July 23, 1984
Days to Decision 97 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 129d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 471
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K841562.
IVAC C80014 Y SOLUTION ADMIN. SET
K843185 · Y · Sep 1984
FLUID ADMINISTRATION LINE W/SPIKE 14-923
K842858 · Norton Performance Plastics Corp. · Sep 1984
T-TYPE IV EXTENSION SET
K843249 · Strato Medical Corp. · Sep 1984
SYRINGE ADDITIVE IV ADMIN. SETS
K841361 · Quest Medical, Inc. · May 1984
HARVARD ANTI-REFLUX Y-SET
K840760 · C.R. Bard, Inc. · Apr 1984
QUIK LOK
K840878 · Abbott Laboratories · Mar 1984